Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of Morgan Stanley NYSE: MS. In a filing disclosed on May 06th, the Representative disclosed that they had bought between $1,001 and $15,000 in Morgan Stanley stock on May 5th. The trade occurred in the Representative's "MARJORIE IRA" account.
Representative Marjorie Taylor Greene also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Occidental Petroleum NYSE: OXY on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Paychex NASDAQ: PAYX on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of MercadoLibre NASDAQ: MELI on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of BP NYSE: BP on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of BHP Group NYSE: BHP on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Advanced Micro Devices NASDAQ: AMD on 5/5/2025.
- Purchased $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOG on 5/5/2025.
Morgan Stanley Trading Down 0.2 %
MS stock traded down $0.22 during midday trading on Friday, reaching $121.66. 4,240,066 shares of the company traded hands, compared to its average volume of 6,680,424. The firm has a market capitalization of $195.18 billion, a price-to-earnings ratio of 15.32, a P/E/G ratio of 1.18 and a beta of 1.30. The company has a debt-to-equity ratio of 3.14, a quick ratio of 0.80 and a current ratio of 0.80. The business has a 50 day moving average of $114.39 and a 200-day moving average of $124.76. Morgan Stanley has a 52-week low of $90.94 and a 52-week high of $142.03.
Morgan Stanley (NYSE:MS - Get Free Report) last released its quarterly earnings results on Friday, April 11th. The financial services provider reported $2.60 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.39. Morgan Stanley had a return on equity of 14.39% and a net margin of 12.48%. The company had revenue of $17.74 billion for the quarter, compared to analyst estimates of $16.81 billion. During the same quarter in the prior year, the firm posted $2.02 EPS. Morgan Stanley's quarterly revenue was up 17.2% compared to the same quarter last year. As a group, sell-side analysts expect that Morgan Stanley will post 8.56 earnings per share for the current fiscal year.
Morgan Stanley Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Wednesday, April 30th will be paid a dividend of $0.925 per share. The ex-dividend date of this dividend is Wednesday, April 30th. This represents a $3.70 annualized dividend and a yield of 3.04%. Morgan Stanley's payout ratio is currently 43.43%.
Institutional Investors Weigh In On Morgan Stanley
Institutional investors have recently added to or reduced their stakes in the stock. Lindbrook Capital LLC boosted its holdings in shares of Morgan Stanley by 1.2% in the 4th quarter. Lindbrook Capital LLC now owns 6,156 shares of the financial services provider's stock valued at $774,000 after buying an additional 73 shares in the last quarter. 1ST Source Bank boosted its stake in Morgan Stanley by 0.5% in the fourth quarter. 1ST Source Bank now owns 15,925 shares of the financial services provider's stock valued at $2,002,000 after acquiring an additional 73 shares in the last quarter. Moors & Cabot Inc. grew its holdings in Morgan Stanley by 1.6% in the fourth quarter. Moors & Cabot Inc. now owns 4,727 shares of the financial services provider's stock worth $594,000 after purchasing an additional 76 shares during the last quarter. DGS Capital Management LLC increased its position in shares of Morgan Stanley by 1.8% during the fourth quarter. DGS Capital Management LLC now owns 4,408 shares of the financial services provider's stock worth $554,000 after purchasing an additional 77 shares in the last quarter. Finally, Omnia Family Wealth LLC lifted its holdings in shares of Morgan Stanley by 2.5% during the 4th quarter. Omnia Family Wealth LLC now owns 3,140 shares of the financial services provider's stock valued at $395,000 after purchasing an additional 77 shares during the last quarter. Institutional investors own 84.19% of the company's stock.
Insider Transactions at Morgan Stanley
In other news, insider Eric F. Grossman sold 10,068 shares of the firm's stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $111.65, for a total value of $1,124,092.20. Following the completion of the transaction, the insider now directly owns 199,274 shares in the company, valued at $22,248,942.10. This trade represents a 4.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Andrew M. Saperstein sold 40,000 shares of Morgan Stanley stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $120.00, for a total value of $4,800,000.00. Following the sale, the insider now directly owns 335,765 shares of the company's stock, valued at $40,291,800. This trade represents a 10.64 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,868 shares of company stock valued at $6,019,548 in the last quarter. 0.19% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. UBS Group increased their price objective on shares of Morgan Stanley from $130.00 to $140.00 and gave the stock a "neutral" rating in a research report on Tuesday, January 21st. JMP Securities restated a "market perform" rating on shares of Morgan Stanley in a report on Monday, April 14th. Wells Fargo & Company reduced their target price on Morgan Stanley from $130.00 to $120.00 and set an "equal weight" rating on the stock in a research note on Monday, April 14th. Bank of America lowered their target price on shares of Morgan Stanley from $150.00 to $144.00 and set a "buy" rating for the company in a research note on Wednesday, April 2nd. Finally, The Goldman Sachs Group reduced their price target on shares of Morgan Stanley from $144.00 to $126.00 and set a "neutral" rating on the stock in a research note on Wednesday, March 19th. Twelve investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $132.46.
View Our Latest Stock Report on Morgan Stanley
About Representative Greene
Marjorie Taylor Greene (Republican Party) is a member of the U.S. House, representing Georgia's 14th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.
Greene (Republican Party) is running for re-election to the U.S. House to represent Georgia's 14th Congressional District. She declared candidacy for the 2026 election.
About Morgan Stanley
(
Get Free Report)
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
